-
1
-
-
84883172231
-
Justices, 9-0, bar patenting human genes
-
June 13 Available: Accessed 09 July 13
-
Liptak A (June 13, 2013) Justices, 9-0, bar patenting human genes. New York Times online. Available: http://www.nytimes.com/2013/06/14/us/supreme-court-rules-human-genes-may-not-be-patented.html?hpw. Accessed 09 July 13.
-
(2013)
New York Times online
-
-
Liptak, A.1
-
2
-
-
84883101512
-
-
Supreme Court of the United States Myriad Genetics, Inc.,et al. Certiorari to the United States Court of Appeals for the Federal Circuit. No. 12-398. Available. Accessed 09 July 13
-
Supreme Court of the United States (2013) Syllabus: Association for Molecular Pathologyet al. v. Myriad Genetics, Inc.,et al. Certiorari to the United States Court of Appeals for the Federal Circuit. No. 12-398. Available: http://www.supremecourt.gov/opinions/12pdf/12-398_1b7d.pdf. Accessed 09 July 13.
-
(2013)
Syllabus: Association for Molecular Pathologyet al. v
-
-
-
3
-
-
84881229755
-
-
June 16 Available:. Accessed 09 July 13
-
Munro D (June 16, 2013) Supreme Court breaks Myriad monopoly. Forbes online. Available: http://www.forbes.com/sites/danmunro/2013/06/16/supreme-court-breaks-myriad-monopoly/. Accessed 09 July 13.
-
(2013)
Supreme Court breaks Myriad monopoly. Forbes online
-
-
Munro, D.1
-
4
-
-
84878302099
-
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
-
doi 10.1371/journal.pmed.1001453
-
Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, et al. (2013) Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value. PLoS Med 10 (5):: e1001453 doi:10.1371/journal.pmed.1001453.
-
(2013)
PLoS Med
, vol.10
, Issue.5
-
-
Marisa, L.1
de Reyniès, A.2
Duval, A.3
Selves, J.4
Gaub, M.P.5
-
5
-
-
84881261591
-
Multiplex Identification of Gram-Positive Bacteria and Resistance Determinants Directly from Positive Blood Culture Broths: Evaluation of an Automated Microarray-Based Nucleic Acid Test
-
doi 10.1371/journal.pmed.1001478
-
Buchan BW, Ginocchio CC, Manii R, Cavagnolo R, Pancholi P, et al. (2013) Multiplex Identification of Gram-Positive Bacteria and Resistance Determinants Directly from Positive Blood Culture Broths: Evaluation of an Automated Microarray-Based Nucleic Acid Test. PLoS Med 10 (7):: e1001478 doi:10.1371/journal.pmed.1001478.
-
(2013)
PLoS Med
, vol.10
, Issue.7
-
-
Buchan, B.W.1
Ginocchio, C.C.2
Manii, R.3
Cavagnolo, R.4
Pancholi, P.5
-
6
-
-
79957877143
-
UK plans 30% funding bump for translational research
-
doi 10.1038/nm0411-394b
-
Perks B, (2011) UK plans 30% funding bump for translational research. Nat Med 17: 394 doi:10.1038/nm0411-394b.
-
(2011)
Nat Med
, vol.17
, pp. 394
-
-
Perks, B.1
-
8
-
-
84881253940
-
Progress in Using Systematic Reviews of Animal Studies to Improve Translational Research
-
doi 10.1371/journal.pmed.1001482
-
Hooijmans CR, Ritskes-Hoitinga M, (2013) Progress in Using Systematic Reviews of Animal Studies to Improve Translational Research. PLoS Med 10 (7):: e1001482 doi:10.1371/journal.pmed.1001482.
-
(2013)
PLoS Med
, vol.10
, Issue.7
-
-
Hooijmans, C.R.1
Ritskes-Hoitinga, M.2
-
9
-
-
79958140708
-
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
-
doi 10.4103/0976-500X.72351
-
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG, (2010) Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. J Pharmacol Pharmacother 1: 94-99 doi: 10.4103/0976-500X.72351.
-
(2010)
J Pharmacol Pharmacother
, vol.1
, pp. 94-99
-
-
Kilkenny, C.1
Browne, W.J.2
Cuthill, I.C.3
Emerson, M.4
Altman, D.G.5
-
10
-
-
84881240391
-
Threats to Validity in the Design and Conduct of Preclinical Efficacy Studies: A Systematic Review of Guidelines for In Vivo Animal Experiments
-
doi 10.1371/journal.pmed.1001489
-
Henderson VC, Kimmelman J, Fergusson D, Grimshaw JM, Hackam DG, (2013) Threats to Validity in the Design and Conduct of Preclinical Efficacy Studies: A Systematic Review of Guidelines for In Vivo Animal Experiments. PLoS Med 10 (7):: e1001489 doi:10.1371/journal.pmed.1001489.
-
(2013)
PLoS Med
, vol.10
, Issue.7
-
-
Henderson, V.C.1
Kimmelman, J.2
Fergusson, D.3
Grimshaw, J.M.4
Hackam, D.G.5
-
12
-
-
20244370885
-
Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing
-
Raja S, Ching J, Xi L, Hughes SJ, Chang R, et al. (2005) Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem 51: 882-890.
-
(2005)
Clin Chem
, vol.51
, pp. 882-890
-
-
Raja, S.1
Ching, J.2
Xi, L.3
Hughes, S.J.4
Chang, R.5
-
13
-
-
73949120420
-
Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
-
doi 10.1128/JCM.01463-09
-
Helb D, Jones M, Story E, Boehme C, Wallace E, et al. (2010) Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology. J Clin Microbiol 48: 229-237 doi:10.1128/JCM.01463-09.
-
(2010)
J Clin Microbiol
, vol.48
, pp. 229-237
-
-
Helb, D.1
Jones, M.2
Story, E.3
Boehme, C.4
Wallace, E.5
-
14
-
-
79960923478
-
GeneXpert-A Game-Changer for Tuberculosis Control?
-
doi 10.1371/journal.pmed.1001064
-
Evans CA, (2011) GeneXpert-A Game-Changer for Tuberculosis Control? PLoS Med 8 (7):: e1001064 doi:10.1371/journal.pmed.1001064.
-
(2011)
PLoS Med
, vol.8
, Issue.7
-
-
Evans, C.A.1
-
15
-
-
79960920501
-
Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
-
doi 10.1371/journal.pmed.1001067
-
Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, et al. (2011) Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study. PLoS Med 8 (7):: e1001067 doi:10.1371/journal.pmed.1001067.
-
(2011)
PLoS Med
, vol.8
, Issue.7
-
-
Lawn, S.D.1
Brooks, S.V.2
Kranzer, K.3
Nicol, M.P.4
Whitelaw, A.5
-
16
-
-
82455205785
-
Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis
-
doi 10.1371/journal.pmed.1001120
-
Vassall A, van Kampen S, Sohn H, Michael JS, John KR, et al. (2011) Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis. PLoS Med 8 (11):: e1001120 doi:10.1371/journal.pmed.1001120.
-
(2011)
PLoS Med
, vol.8
, Issue.11
-
-
Vassall, A.1
van Kampen, S.2
Sohn, H.3
Michael, J.S.4
John, K.R.5
|